Newsroom
Check out the latest headlines featuring Prenosis
LifeBridge Health deploys Prenosis’ FDA-authorized AI tool to speed sepsis detection
Read More →
Following their North Star: Illini-founded company revolutionizing sepsis care
Read More →
Prenosis Achieves SOC 2 Type II Compliance, Reinforces Commitment to Data Security
Read More →
BioAegis Therapeutics Announces Collaboration with Prenosis to Advance AI-Driven Precision Medicine in Inflammatory Disease
Read More →
Sepsis-finding biotech Prenosis lands $40M in financing, federal contract
Read More →
Prenosis Secures $40M to Advance Precision Medicine Infrastructure for Critical Care
Read More →
Chicago biotech startup Prenosis raises $40M to advance AI sepsis diagnostic tool
Read More →
Prenosis Secures $40M to Build the Precision Medicine Network for Critical Care
Read More →
Prenosis Announces $20M BARDA Contract and $20M Series A Financing Round, Advancing Mission to Deliver Integrated Diagnostics and Therapeutics
Read More →
Prenosis Named Winner of the 24th Annual Chicago Innovation Awards
Read More →
Prenosis Named Finalist in 2025 Digital Health Hub Foundation Awards
Read More →
New ICD-10-PCS Code Available for AI Sepsis Diagnostic Tools
Read More →
LifeBridge Health deploys Prenosis’ FDA-authorized AI tool to speed sepsis detection
Read More →
Following their North Star: Illini-founded company revolutionizing sepsis care
Read More →
Sepsis-finding biotech Prenosis lands $40M in financing, federal contract
Read More →
Prenosis Secures $40M to Advance Precision Medicine Infrastructure for Critical Care
Read More →
Chicago biotech startup Prenosis raises $40M to advance AI sepsis diagnostic tool
Read More →
Prenosis Secures $40M to Build the Precision Medicine Network for Critical Care
Read More →
High-Profile Start-Ups Inato And Prenosis Show AI ‘Best Practice’
Read More →
Sepsis ImmunoScore® Featured in JAMA
Read More →
Prenosis CEO Bobby Reddy, Jr. Recognized Among Crain’s Chicago 40 Under 40
Read More →
Bobby Reddy, Jr. Discusses the Transformative Impact of AI on Sepsis Care–NewsNation Now
Read More →
Roche to distribute Prenosis’ AI sepsis detection tool in US–MedTech Dive
Read More →
Roche picks up Prenosis’ newly cleared sepsis AI tool for distribution–Fierce Biotech
Read More →
Prenosis Achieves SOC 2 Type II Compliance, Reinforces Commitment to Data Security
Read More →
BioAegis Therapeutics Announces Collaboration with Prenosis to Advance AI-Driven Precision Medicine in Inflammatory Disease
Read More →
Prenosis Announces $20M BARDA Contract and $20M Series A Financing Round, Advancing Mission to Deliver Integrated Diagnostics and Therapeutics
Read More →
Prenosis Named Winner of the 24th Annual Chicago Innovation Awards
Read More →
Prenosis Named Finalist in 2025 Digital Health Hub Foundation Awards
Read More →
New ICD-10-PCS Code Available for AI Sepsis Diagnostic Tools
Read More →
Prenosis Named One of the Top 100 Finalists for the 24th Annual Chicago Innovation Awards
Read More →
Prenosis Named Quarterfinalist in 2025 Digital Health Hub Foundation Awards
Read More →
Sepsis ImmunoScore Named Honoree in Fast Company’s 2025 World Changing Ideas Awards
Read More →
Bobby Reddy, Jr. Named to TIME’s 2025 TIME100 Health List
Read More →
Study published in the New England Journal of Medicine AI Concludes that the Sepsis ImmunoScore™, the First FDA-Authorized AI Tool for Sepsis, has both significant Diagnostic and Predictive Power
Read More →
Sepsis ImmunoScore™ Named a TIME Best Invention of 2024
Read More →